Section 5: Patient safety and quality assurance最新文献

筛选
英文 中文
5PSQ-034 Comparison of toxicity in clinical practice of anti-PD-1/PD-L1 antibodies in monotherapy in non-small-cell lung cancer 5PSQ-034 抗PD-1/PD-L1抗体单药治疗非小细胞肺癌临床实践中的毒性比较
Section 5: Patient safety and quality assurance Pub Date : 2024-03-01 DOI: 10.1136/ejhpharm-2024-eahp.368
I. Patier, AC Cercos-Lleti
{"title":"5PSQ-034 Comparison of toxicity in clinical practice of anti-PD-1/PD-L1 antibodies in monotherapy in non-small-cell lung cancer","authors":"I. Patier, AC Cercos-Lleti","doi":"10.1136/ejhpharm-2024-eahp.368","DOIUrl":"https://doi.org/10.1136/ejhpharm-2024-eahp.368","url":null,"abstract":"","PeriodicalId":107680,"journal":{"name":"Section 5: Patient safety and quality assurance","volume":"16 8","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140269101","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
5PSQ-055 Efficacy and safety of dalbavancin in gram-positive infections treatment 5PSQ-055 达巴万星治疗革兰氏阳性感染的有效性和安全性
Section 5: Patient safety and quality assurance Pub Date : 2024-03-01 DOI: 10.1136/ejhpharm-2024-eahp.389
L. Amaro, C. Moya, R. Castillejo
{"title":"5PSQ-055 Efficacy and safety of dalbavancin in gram-positive infections treatment","authors":"L. Amaro, C. Moya, R. Castillejo","doi":"10.1136/ejhpharm-2024-eahp.389","DOIUrl":"https://doi.org/10.1136/ejhpharm-2024-eahp.389","url":null,"abstract":"","PeriodicalId":107680,"journal":{"name":"Section 5: Patient safety and quality assurance","volume":"23 6","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140269315","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
5PSQ-115 Evaluation of hypothyroidism associated with apalutamide and enzalutamide treatment in metastatic prostate cancer using the European adverse effect database (EudraVigilance) 5PSQ-115 利用欧洲不良反应数据库(EudraVigilance)评估与阿帕鲁胺和恩扎鲁胺治疗转移性前列腺癌相关的甲状腺功能减退症
Section 5: Patient safety and quality assurance Pub Date : 2024-03-01 DOI: 10.1136/ejhpharm-2024-eahp.449
F. Cajade, M. Touris Lores, I. Soto-Baselga, B. Bernárdez-Ferrán, S. Santana-Martínez, I. Zarra-Ferro
{"title":"5PSQ-115 Evaluation of hypothyroidism associated with apalutamide and enzalutamide treatment in metastatic prostate cancer using the European adverse effect database (EudraVigilance)","authors":"F. Cajade, M. Touris Lores, I. Soto-Baselga, B. Bernárdez-Ferrán, S. Santana-Martínez, I. Zarra-Ferro","doi":"10.1136/ejhpharm-2024-eahp.449","DOIUrl":"https://doi.org/10.1136/ejhpharm-2024-eahp.449","url":null,"abstract":"","PeriodicalId":107680,"journal":{"name":"Section 5: Patient safety and quality assurance","volume":"143 3","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140271007","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
5PSQ-091 Suitability of teriparatide and level of acceptance of pharmacotherapeutic recommendations in an area of health management 5PSQ-091 特立帕肽的适用性和健康管理领域对药物治疗建议的接受程度
Section 5: Patient safety and quality assurance Pub Date : 2024-03-01 DOI: 10.1136/ejhpharm-2024-eahp.425
AY Salmeron Cobos, A. Rodríguez Delgado, MI Archilla Amat, MR Cantudo Cuenca, A. Jiménez Morales
{"title":"5PSQ-091 Suitability of teriparatide and level of acceptance of pharmacotherapeutic recommendations in an area of health management","authors":"AY Salmeron Cobos, A. Rodríguez Delgado, MI Archilla Amat, MR Cantudo Cuenca, A. Jiménez Morales","doi":"10.1136/ejhpharm-2024-eahp.425","DOIUrl":"https://doi.org/10.1136/ejhpharm-2024-eahp.425","url":null,"abstract":"","PeriodicalId":107680,"journal":{"name":"Section 5: Patient safety and quality assurance","volume":"40 3","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140271398","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
5PSQ-079 Pharmaceutical interventions in a health management area 5PSQ-079 健康管理领域的药物干预措施
Section 5: Patient safety and quality assurance Pub Date : 2024-03-01 DOI: 10.1136/ejhpharm-2024-eahp.413
Mdp Sáez Carballo, Y. Domínguez Rivas, AB Morillo Mora, V. González Rosa, M. Zaragoza Rascón, J. González-Miret Martín
{"title":"5PSQ-079 Pharmaceutical interventions in a health management area","authors":"Mdp Sáez Carballo, Y. Domínguez Rivas, AB Morillo Mora, V. González Rosa, M. Zaragoza Rascón, J. González-Miret Martín","doi":"10.1136/ejhpharm-2024-eahp.413","DOIUrl":"https://doi.org/10.1136/ejhpharm-2024-eahp.413","url":null,"abstract":"","PeriodicalId":107680,"journal":{"name":"Section 5: Patient safety and quality assurance","volume":"229 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140274093","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
5PSQ-029 The overriding of drug safety alerts fired by the clinical decision support tool: evaluation of appropriate responses and alert fatigue solutions 5PSQ-029 覆盖临床决策支持工具发出的药物安全警报:评估适当的反应和警报疲劳解决方案
Section 5: Patient safety and quality assurance Pub Date : 2024-03-01 DOI: 10.1136/ejhpharm-2024-eahp.363
A. Ansari, K. Albogami, AF Alwadie, A. Alzahrani, A. Alshomrani, AM Alshehri, K. Al-Harbi, D. Asraf
{"title":"5PSQ-029 The overriding of drug safety alerts fired by the clinical decision support tool: evaluation of appropriate responses and alert fatigue solutions","authors":"A. Ansari, K. Albogami, AF Alwadie, A. Alzahrani, A. Alshomrani, AM Alshehri, K. Al-Harbi, D. Asraf","doi":"10.1136/ejhpharm-2024-eahp.363","DOIUrl":"https://doi.org/10.1136/ejhpharm-2024-eahp.363","url":null,"abstract":"","PeriodicalId":107680,"journal":{"name":"Section 5: Patient safety and quality assurance","volume":"569 ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140274367","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
5PSQ-103 Vancomycin-induced renal toxicity through therapeutic drug monitoring in daily practice 5PSQ-103 通过日常实践中的治疗药物监测发现万古霉素诱发的肾毒性
Section 5: Patient safety and quality assurance Pub Date : 2024-03-01 DOI: 10.1136/ejhpharm-2024-eahp.437
A. Magdalena Pérez, J. Peña Hernández, A. Santos Fagundo, J. Esquivel Negrín, C. Frias Ruiz, P. Joy Carmona, A. Martín López, E. Tévar Afonso, M. Carretero Pérez, FJ Merino Alonso
{"title":"5PSQ-103 Vancomycin-induced renal toxicity through therapeutic drug monitoring in daily practice","authors":"A. Magdalena Pérez, J. Peña Hernández, A. Santos Fagundo, J. Esquivel Negrín, C. Frias Ruiz, P. Joy Carmona, A. Martín López, E. Tévar Afonso, M. Carretero Pérez, FJ Merino Alonso","doi":"10.1136/ejhpharm-2024-eahp.437","DOIUrl":"https://doi.org/10.1136/ejhpharm-2024-eahp.437","url":null,"abstract":"","PeriodicalId":107680,"journal":{"name":"Section 5: Patient safety and quality assurance","volume":"156 ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140274559","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
5PSQ-053 Effectiveness and safety of galcanezumab. Real-life results 5PSQ-053 galcanezumab 的有效性和安全性。实际结果
Section 5: Patient safety and quality assurance Pub Date : 2024-03-01 DOI: 10.1136/ejhpharm-2024-eahp.387
S. García Lastra, E. Crespo Rodriguez, P. Andreu Margullon, A. Romero Garcia, I. Zapico Garcia, AI Plano Sánchez, C. Carriles Fernandez, N. Perez Domínguez, JA Valdueza Beneitez, N. Gonzalez Sanchez
{"title":"5PSQ-053 Effectiveness and safety of galcanezumab. Real-life results","authors":"S. García Lastra, E. Crespo Rodriguez, P. Andreu Margullon, A. Romero Garcia, I. Zapico Garcia, AI Plano Sánchez, C. Carriles Fernandez, N. Perez Domínguez, JA Valdueza Beneitez, N. Gonzalez Sanchez","doi":"10.1136/ejhpharm-2024-eahp.387","DOIUrl":"https://doi.org/10.1136/ejhpharm-2024-eahp.387","url":null,"abstract":"","PeriodicalId":107680,"journal":{"name":"Section 5: Patient safety and quality assurance","volume":"44 19","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140276226","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
5PSQ-114 Head and neck erythema associated with the use of dupilumab in patients with atopic dermatitis 5PSQ-114 与特应性皮炎患者使用杜匹单抗有关的头颈部红斑
Section 5: Patient safety and quality assurance Pub Date : 2024-03-01 DOI: 10.1136/ejhpharm-2024-eahp.448
I. Baena Bocero, N. Revilla Cuesta, S. Arnaiz Diez, MT Esteban, L. Sanchez Luque, JB Agueda Fernandez, A. Miguel Dominguez, E. Briones Cuesta, Z. Rodriguez Fernandez, M. Güemes García
{"title":"5PSQ-114 Head and neck erythema associated with the use of dupilumab in patients with atopic dermatitis","authors":"I. Baena Bocero, N. Revilla Cuesta, S. Arnaiz Diez, MT Esteban, L. Sanchez Luque, JB Agueda Fernandez, A. Miguel Dominguez, E. Briones Cuesta, Z. Rodriguez Fernandez, M. Güemes García","doi":"10.1136/ejhpharm-2024-eahp.448","DOIUrl":"https://doi.org/10.1136/ejhpharm-2024-eahp.448","url":null,"abstract":"","PeriodicalId":107680,"journal":{"name":"Section 5: Patient safety and quality assurance","volume":"91 ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140278111","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
5PSQ-007 A review of medication reconciliation in the perioperative period: variables that lead to medication errors 5PSQ-007 围手术期药物调节回顾:导致用药错误的变量
Section 5: Patient safety and quality assurance Pub Date : 2024-03-01 DOI: 10.1136/ejhpharm-2024-eahp.341
DJ Boardman González, L. Rubio Alonso, S. Canales Ugarte, V. Lafarga Lapieza, P. Hernando Martínez, D. Barreda Hernández
{"title":"5PSQ-007 A review of medication reconciliation in the perioperative period: variables that lead to medication errors","authors":"DJ Boardman González, L. Rubio Alonso, S. Canales Ugarte, V. Lafarga Lapieza, P. Hernando Martínez, D. Barreda Hernández","doi":"10.1136/ejhpharm-2024-eahp.341","DOIUrl":"https://doi.org/10.1136/ejhpharm-2024-eahp.341","url":null,"abstract":"","PeriodicalId":107680,"journal":{"name":"Section 5: Patient safety and quality assurance","volume":"499 4","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140281789","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信